Ann: Oral nadolol data presented to American Thoracic Society, page-5

Just about every presentation refers to business development or partners and potential partners. The word partner can refer to people like 3M who are developing the device for oral Nadilol, or have already developed it. I think that there would be a long list of major and not so major pharmas who have been approached and have had some discussions. That is how these companies work. They need contacts and some relationship before the results of a trial are known. The recent presentation to the APS was just one more chance to spruik their wares. One point about this presentation is that the association is the most prestigious in the field and IVX would not get an opportunity to present unless a few very well informed people believed that the research was at the forefront of the field and exciting.